Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
170.94
-0.24 (-0.14%)
Nov 28, 2025, 4:00 PM EST - Market closed
Repligen Stock Forecast
Stock Price Forecast
The 10 analysts that cover Repligen stock have a consensus rating of "Buy" and an average price target of $170.9, which forecasts a -0.02% decrease in the stock price over the next year. The lowest target is $135 and the highest is $204.
Price Target: $170.9 (-0.02%)
Analyst Consensus: Buy
* Price targets were last updated on Oct 29, 2025.
Analyst Ratings
The average analyst rating for Repligen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 1 | 2 | 2 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 4 | 4 | 4 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 10 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $150 → $165 | Hold | Maintains | $150 → $165 | -3.47% | Oct 29, 2025 |
| Barclays | Barclays | Buy Maintains $160 → $175 | Buy | Maintains | $160 → $175 | +2.38% | Oct 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $155 → $175 | Buy | Maintains | $155 → $175 | +2.38% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $150 → $160 | Buy | Maintains | $150 → $160 | -6.40% | Oct 2, 2025 |
| HSBC | HSBC | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | -12.25% | Oct 1, 2025 |
Financial Forecast
Revenue This Year
745.48M
from 634.44M
Increased by 17.50%
Revenue Next Year
840.48M
from 745.48M
Increased by 12.74%
EPS This Year
1.70
from -0.46
EPS Next Year
2.15
from 1.70
Increased by 26.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 771.3M | 889.5M | ||||
| Avg | 745.5M | 840.5M | ||||
| Low | 700.7M | 778.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21.6% | 19.3% | ||||
| Avg | 17.5% | 12.7% | ||||
| Low | 10.4% | 4.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.79 | 2.59 | ||||
| Avg | 1.70 | 2.15 | ||||
| Low | 1.62 | 1.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 52.3% | ||||
| Avg | - | 26.1% | ||||
| Low | - | 1.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.